Home

Market Capitalization of Piramal Pharma Ltd

Image

Piramal Pharma Ltd

NSE: PPLPHARMA

Market Cap

₹ 30545.24 crore

Last updated on: Feb 05, 2025

Key Highlights

  • The Market Cap of Piramal Pharma Ltd is ₹ 30545 crore as of 05 Feb 25 .
  • The Latest Trading Price of Piramal Pharma Ltd is ₹ 230.4 as of 05 Feb 15:30 .
  • The Dividend Payouts of Piramal Pharma Ltd is ₹ 0.11 as of Jul 12, 2024 .
Image

Piramal Pharma Ltd

NSE: PPLPHARMA

Share Price

₹ 230.4

3.35 (1.48%)

stock direction

Last updated on: Feb 05, 2025

Market Price of Piramal Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Piramal Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
05 Feb 2025230.4
04 Feb 2025227.05
03 Feb 2025231.55
01 Feb 2025229.7
31 Jan 2025232.9
30 Jan 2025231.05
29 Jan 2025239.7
28 Jan 2025218.95
27 Jan 2025224
24 Jan 2025233

SWOT Analysis Of Piramal Pharma Ltd

Strength

3

che

Weakness

1

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Piramal Pharma Ltd

Asset Value vs Market Value of Piramal Pharma Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of Market Cap

Key Valuation Metric of Piramal Pharma Ltd

No data available

No data available

Historical P/E Ratio of Piramal Pharma Ltd

No data available

* All values are in %

Historical Revenue of Piramal Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Piramal Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Piramal Pharma Ltd

No data available

* All values are in crore

Image

Piramal Pharma Ltd

NSE: PPLPHARMA

DIVIDENDPAYOUT

₹ -

Last updated on: Jul 12, 2025

About Piramal Pharma Ltd

  • Piramal Pharma Limited was incorporated on March 4, 2020 as a Public Limited Company and registered with the RoC. The Company offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 17 global facilities and a global distribution network in over 100 countries.
  • It includes an integrated CDMO business, CHG business and ICH business, selling over-the-counter products in India.
  • In addition, it has a joint venture with Allergan, a leader in ophthalmology in the Indian formulations market. Piramal Pharma Solution provides integrated drug discovery, development, and manufacturing services for both drug substances, i.e. active pharmaceutical ingredients (APIs) and drug products, i.e. formulations across the life cycle of a molecule, from discovery and clinical development to commercial launch.

Piramal Pharma Ltd News Hub

Piramal Pharma receives SBTi validation for its GHG commitment

Piramal Pharma has embarked on its sustainability journey as the Science Based Targets initiative (S

Read more

17 Sept 24

Piramal Pharma to invest $80M to expand its Lexington, Kentucky facility

Piramal Pharma Solutions (PPS), a leading global Contract Development and Manufacturing Organization

Read more

30 Sept 24

Piramal Pharma to discuss results

Piramal Pharma will hold a meeting of the Board of Directors of the Company on 28 January 2025. Powe

Read more

14 Jan 25

Piramal Pharma to declare Quarterly Result

Piramal Pharma will hold a meeting of the Board of Directors of the Company on 23 October 2024. Powe

Read more

15 Oct 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Piramal Pharma Ltd Market Cap

What is the market cap of Piramal Pharma Ltd?

As of February 5, 2025, Piramal Pharma Ltd has a market capitalization of ₹30545.24, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Piramal Pharma Ltd's market capitalization?

Piramal Pharma Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Piramal Pharma Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Piramal Pharma Ltd's market capitalization change?

Piramal Pharma Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions